Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of ARHGEF3 mRNA | increases expression | 19933214
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ARHGEF3 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ARHGEF3 mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ARHGEF3 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ARHGEF3 mRNA | increases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ARHGEF3 mRNA | increases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of ARHGEF3 mRNA | decreases expression | 16002434
|
C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA | affects cotreatment|increases expression | 16996129
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ARHGEF3 mRNA | increases expression | 18301758
|
D011374 |
Progesterone |
Progesterone results in increased expression of ARHGEF3 mRNA | increases expression | 18070364
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ARHGEF3 mRNA | increases expression | 19933214
|
C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA | affects cotreatment|increases expression | 16996129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 14514962 11752688 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.57 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.64 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.01 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.71 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
5.07 | 17312309 11697798 16778634 19442620 16121404 15867366 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.81 | 18404659 8053405 11869084 16769263 15845617 18496637 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.51 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.40 | 15845082 15380490 15665606 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.38 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.38 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.38 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.38 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
2.38 | 18695136 16096432 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.67 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.67 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.67 | 12907637 12619106 21507988 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.57 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
3.90 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.79 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.79 | 11237771 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.82 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.82 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.03 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.03 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 16354765 15668235 8697196 12621046 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.88 | 16142594 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.36 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.36 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.63 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.34 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.34 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
9.74 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.74 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.28 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.28 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.03 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.93 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.93 | 19236843 20131406 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.98 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.63 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.63 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.33 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
5.16 | 19622757 18089816 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18670907 18850075 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.37 | 12669777 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.54 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.15 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.15 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.40 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.91 | 12371664 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.88 | 18089816 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.16 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.16 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.64 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.64 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.64 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.64 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.64 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.19 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.19 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.19 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.42 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.42 | 20464547 20064080 18816296 18520028 6695378 20869020 20135361 17053015 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.42 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.71 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
6.71 | 17312309 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.79 | 16675582 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
8.43 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
8.43 | 18089719 19621390 16996129 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.87 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.87 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
3.68 | 15867366 17312309 19139120 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.99 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.99 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.23 | 16049721 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.52 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
4.10 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.55 | 17393432 16525653 |
MESH:D010146 |
Pain |
|
zoledronic acid |
4.03 | 16475674 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11222880 11118676 11896295 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.93 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.69 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.69 | 18247401 15754350 16289102 16644109 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
2.69 | 19103299 12438248 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.89 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
5.06 | 16121404 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.11 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.11 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.63 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.63 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.43 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.50 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.50 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.50 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.51 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.51 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |